|
| GSTM1 |
|
| ||
Variables | Null | Active | OR | 95% CI | p-value | |
Study population | Controls (n = 100) | 25 | 75 | Ref |
|
|
Cases (n = 209) | 167 | 42 | 11.92 | 6.77 - 20.99 | <0.0001 | |
HSIL (n = 101) | 79 | 22 | 10.77 | 5.59 - 20.72 | <0.0001 | |
CIN2 (n = 75) | 60 | 15 | 12.00 | 5.81 - 24.76 | <0.0001 | |
CIN3 (n = 26) | 19 | 7 | 8.14 | 3.06 - 21.64 | <0.0001 | |
Cancer (n = 108) | 88 | 20 | 13.20 | 6.79 - 25.63 | <0.0001 | |
Adenocarcinoma (n = 9) | 7 | 2 | 10.50 | 2.04 - 53.88 | 0.0025 | |
Squamous cell carcinoma (n = 99) | 81 | 18 | 13.50 | 6.82 - 26.71 | <0.0001 | |
Total (n = 309) | 192 | 117 |
|
|
|